You are here

rare disease

Eidos Therapeutics raises $106M IPO to advance ATTR med

Eidos Therapeutics raises $106M IPO to advance ATTR med

Fierce Biotech

Eidos Therapeutics

Flag link:

Pfizer's rare heart disease drug succeeds in late-stage study

Pfizer's rare heart disease drug succeeds in late-stage study

Yahoo/Reuters

clinical trials

transthyretin cardiomyopathy

Ionis Pharmaceuticals

Flag link:

Shire CEO sees Microsoft tie-up building momentum for faster rare disease diagnosis

Shire CEO sees Microsoft tie-up building momentum for faster rare disease diagnosis

Fierce Pharma

Flemming Ornskov

Flag link:

Rare diseases: FDA awards grants over 6 million dollars

Rare diseases: FDA awards grants over 6 million dollars

GoinPharma

Flag link:

Alnylam’s rare disease drug shines in trial, paving way for a brand-new class of medicines

Alnylam’s rare disease drug shines in trial, paving way for a brand-new class of medicines

Stat

familial amyloid polyneuropathy

Flag link:

Smaller sales forces get the job done in rare disease

Smaller sales forces get the job done in rare disease

BioPharma Dive

Taro Pharmaceuticals

Flag link:

Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall

Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall

Endpoints

Rhythm Pharmaceuticals

Flag link:

Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul

Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul

Bloomberg

healthcare reform

Jazz Pharmaceuticals

Vertex Pharmaceuticals

Flag link:

Shire, armed with new rare disease patent, aims to block CSL's Haegarda launch

Shire, armed with new rare disease patent, aims to block CSL's Haegarda launch

Fierce Pharma

hereditary angiodema

Flag link:

Top 25 rare disease brands, by sales

Top 25 rare disease brands, by sales

Medical Marketing and Media

Teva Pharmaceutical

Jazz Pharmaceuticals

Flag link:

Pfizer’s Metabolic, Rare Disease Segments: Hope for the Future?

Pfizer’s Metabolic, Rare Disease Segments: Hope for the Future?

Market Realist

metabolic disorders

Flag link:

4 ways for marketers to differentiate their brands in the rare-disease space

4 ways for marketers to differentiate their brands in the rare-disease space

Medical Marketing and Media

Flag link:

Drugs for rare diseases looming health hazard

Drugs for rare diseases looming health hazard

Toronto Star, Canada

Flag link:

Inspire Launches Online Community to Connect Patients Affected by Pancreatic Neuroendocrine Tumors (PNET)

online comunities

Flag link: